Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retinal microvascular changes in diabetic macular edema treated with Anti-VEGF assessed by swept-source OCTA
TCTR20161010005Phase 3Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Oct 2016
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in diabetic macular edema (DME), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Change in retinal microvascular parameters on swept-source OCTA. Started Oct 2016; status: recruiting.
02
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on TCTR20161010005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161010005.